Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-08-26FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2019-07-01FDA Approved: HALOPERIDOL — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for haloperidol lactate (HALOPERIDOL LACTATE) as a generic injectable from Fresenius Kabi USA, LLC.
-
FDA approval · 2019-06-12FDA Approved: PALIPERIDONE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' generic paliperidone through an original application (ANDA). The approval covers use for schizophrenia.
-
FDA approval · 2019-04-11FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2019-04-05FDA Approved: THIOTHIXENE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original application for thiothixene, a thioxanthene antipsychotic, for the treatment of schizophrenia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-04-04FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for HALOPERIDOL DECANOATE from Somerset Therapeutics, LLC, related to the long-acting antipsychotic …
-
FDA approval · 2019-03-19FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved Zydus Pharmaceuticals USA Inc.'s original application for lurasidone hydrochloride (generic lurasidone).
-
FDA approval · 2019-03-08FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
FDA approved a supplemental application for haloperidol decanoate from Patriot Pharmaceuticals LLC, a long-acting antipsychotic.
-
FDA approval · 2019-03-01FDA Approved: PERPHENAZINE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves the original ANDA for PERPHENAZINE from Rising Pharma Holdings, Inc., making a generic version of the antipsychotic available.
-
FDA approval · 2019-02-21FDA Approved: ARIPIPRAZOLE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for a generic version of aripiprazole.
-
FDA approval · 2019-01-25FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA (paliperidone) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2019-01-25FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approves a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, pertaining to the existin…
-
FDA approval · 2019-01-25FDA Approved: INVEGA HAFYERA — Supplemental Application (Janssen Pharmaceuticals, Inc)
The FDA approved a supplemental application for INVEGA HAFYERA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2019-01-25FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal Consta (risperidone) from Janssen Pharmaceuticals, Inc., indicating a supplemental app…
-
FDA approval · 2019-01-16FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
FDA approval · 2019-01-16FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application to authorize a generic version of Clozapine manufactured by Mylan Pharmaceuticals Inc.
-
FDA approval · 2019-01-16FDA Approved: CLOZAPINE — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's supplemental application for clozapine (generic) under ANDA202873.
-
FDA approval · 2019-01-16FDA Approved: CLOZAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Clozapine from Aurobindo Pharma Limited.
-
FDA approval · 2019-01-16FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva Pharmaceuticals USA, Inc.'s supplemental application for Clozapine (generic) under the ANDA.
-
FDA approval · 2019-01-04FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's generic lurasidone hydrochloride (an Abbreviated New Drug Application) for the treatment of schizophre…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's generic lurasidone hydrochloride via an Original Application (ANDA). The generic is indicated for schizophr…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic lurasidone hydrochloride under an Original ANDA, expanding access to this antipsychotic as a gen…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved Exelan Pharmaceuticals Inc.'s original application for lurasidone hydrochloride (generic lurasidone) capsules.
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's generic LURASIDONE HYDROCHLORIDE (ANDA) for the same indications as the brand Latuda. These indications include schizo…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's Original Application for Lurasidone Hydrochloride (generic lurasidone) for marketing in the U…